AngioDynamics Inc. (ANGO) insider has 2,267 shares withheld for taxes

Rhea-AI Filing Summary

AngioDynamics Inc. executive Lawrence T. Weiss, SVP and Chief Legal Officer, reported an exempt disposition of 2,267 shares of common stock on July 16, 2026. The shares were withheld at $14.14 per share to satisfy tax obligations from vesting restricted stock units granted July 16, 2025, leaving 91,330 shares held directly.

Insider Trade Summary

Net Seller: 2,267 shares

Net Sell 1 txn

Insider Weiss Lawrence T

Role SVP, Chief Legal Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	2,267	$14.14	$32K

Holdings After Transaction: Common Stock — 91,330 shares (Direct)

Footnotes (1)

1. F1. The exempt disposition of 2,267 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.

Key Figures

Shares disposed: 2,267 shares Price per share: $14.14 per share Shares held after transaction: 91,330 shares

3 metrics

Shares disposed 2,267 shares Exempt disposition on July 16, 2026 to satisfy tax withholding obligations

Price per share $14.14 per share Reference price used for the 2,267-share exempt disposition

Shares held after transaction 91,330 shares Directly held by Lawrence T. Weiss following the July 16, 2026 transaction

Key Terms

restricted stock units, tax withholding obligations, exempt disposition

3 terms

restricted stock units financial

"shares underlying restricted stock units granted to the reporting person on July 16, 2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"made to satisfy tax withholding obligations in connection with the pre-determined vesting"

exempt disposition regulatory

"The exempt disposition of 2,267 shares of common stock of AngioDynamics, Inc."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/21/2026 - 08:37 PM Accepted by SEC EDGAR 07/21/2026 - 08:36 PM Learn about SEC filing dates

FAQ

What insider transaction did AngioDynamics (ANGO) disclose?

AngioDynamics reported that SVP and Chief Legal Officer Lawrence T. Weiss had 2,267 common shares withheld on July 16, 2026. The exempt disposition satisfied tax withholding obligations related to vesting restricted stock units granted on July 16, 2025, and was not a discretionary share purchase.

Who is the insider in the latest AngioDynamics (ANGO) filing and what is his role?

The insider is Lawrence T. Weiss, serving as AngioDynamics’ SVP, Chief Legal Officer. He reported an exempt disposition where shares were withheld to cover tax obligations arising from the vesting of previously granted restricted stock units, rather than an open-market stock trade.

Was the AngioDynamics (ANGO) insider transaction a routine tax withholding event?

Yes. The filing describes an exempt disposition of 2,267 shares made to satisfy tax withholding obligations. This occurred in connection with the pre-determined vesting of shares underlying restricted stock units granted on July 16, 2025, indicating a compensation-related event rather than a discretionary sale.

How many AngioDynamics (ANGO) shares does Lawrence T. Weiss hold after the transaction?

After the July 16, 2026 transaction, Lawrence T. Weiss directly holds 91,330 shares of AngioDynamics common stock. This figure reflects his position following the exempt disposition of 2,267 shares withheld to cover tax withholding obligations tied to restricted stock unit vesting.

What price was used for the shares in the AngioDynamics (ANGO) insider tax-withholding transaction?

The 2,267 AngioDynamics shares in the exempt disposition were valued at $14.14 per share. This per-share amount is tied to satisfying tax withholding obligations for the vesting restricted stock units granted to Lawrence T. Weiss on July 16, 2025, as disclosed in the filing.

What triggered the AngioDynamics (ANGO) insider share withholding on July 16, 2026?

The share withholding was triggered by the pre-determined vesting of shares underlying restricted stock units granted to Lawrence T. Weiss on July 16, 2025. To meet related tax withholding obligations, 2,267 shares of AngioDynamics common stock were disposed of in an exempt transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weiss Lawrence T

(Last) (First) (Middle)

14 PLAZA DRIVE

(Street)

LATHAM NEW YORK 12110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ANGIODYNAMICS INC [ ANGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		F		2,267(1)	D	$14.14	91,330	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The exempt disposition of 2,267 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.

	/s/ Lawrence Weiss	07/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)